Cosette Pharmaceuticals Welcomes Vincent Colicchio as Senior Vice President of Operations
In this role, Vin will lead Cosette’s manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation.
Global Pharma | 11/02/2025 | By Aishwarya | 540
US FDA Approves Abbvie's EMBLAVEO
AbbVie announced that the US Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam), as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination antibiotic.
Global Pharma | 10/02/2025 | By Manvi | 640
BioRay's ROR1-Targeting Dual-Epitope ADC BR111 Gains NMPA Clinical Trial Approval
BioRay Pharmaceutical announced that China's NMPA has accepted the clinical trial application for BR111, a first-in-class bi-paratopic ADC targeting ROR1 for the treatment of hematological malignancies and solid tumours.
Global Pharma | 10/02/2025 | By Manvi | 394
Sai Life Sciences Eyes Global Expansion as Revenue Hits INR 1,115.1 Crore
The company reported a 15 percent increase in revenue and a 36 percent rise in net profit compared to the same period last year, driven by strong execution, expanding capacity, and deepening customer relationships.
Global Pharma | 10/02/2025 | By Aishwarya | 1148
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
As an independent company, Tanabe Pharma will continue to build on its legacy of medical innovation while developing new opportunities for growth through business development, licensing activities, enhanced R&D productivity, commercialization and strategic acquisitions.
Global Pharma | 10/02/2025 | By Aishwarya | 448
ClariMed Opens its Advanced Simulated Use Research Center in Cambridge, UK
The new purpose-built facility features innovative design elements that enhance the quality and scope of human factors studies, including a dedicated observation area on the second floor that provides unparalleled visibility of participant interactions.
Global Pharma | 07/02/2025 | By Manvi | 224
Delta Development Team Launches its Cutting-Edge Tricon Refrigerated Containers
Delta Development Team, Inc (DDT) is pushing the boundaries of innovative storage and transport solutions for temperature-sensitive goods with the development of advanced, large-scale refrigerated Tricon containers.
Global Pharma | 07/02/2025 | By Manvi | 332
Aurobindo Pharma to Use Solar Power in Company's Operations to Promote Sustainability
Hyderabad-based Aurobindo Pharma has signed a power purchase agreement with Swarnaaskshu Solar Power to procure solar energy under a captive arrangement. It will be investing up to INR 10.40 crore for a 26 percent stake in the company's planned 30 MW AC (40 MW DC) solar plant in Telangana.
Global Pharma | 07/02/2025 | By Manvi | 800
Bio-Thera's BAT2506 Biosimilar to Simponi Gains EMA Review for EU Approval
The reference medicine golimumab has been approved in Europe for several indications including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis.
Global Pharma | 07/02/2025 | By Abha | 534
Eli Lilly's Omvoh Shows Long-Term Efficacy in Crohn's Disease: VIVID-2 Study Results Announced
Omvoh works to reduce inflammation within the gastrointestinal tract by targeting a specific protein, interleukin-23p19 (IL-23p19), which is a key contributor to intestinal inflammation.
Global Pharma | 07/02/2025 | By Abha | 523
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy